Omnicom Group Total Revenue increased by 12.9% to $6.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 69.2%, from $3.69B to $6.24B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 4.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.57B | $3.44B | $3.86B | $3.41B | $3.57B | $3.44B | $3.87B | $3.44B | $3.61B | $3.58B | $4.06B | $3.63B | $3.85B | $3.88B | $4.32B | $3.69B | $4.02B | $4.04B | $5.53B | $6.24B |
| QoQ Change | — | -3.8% | +12.3% | -11.6% | +4.6% | -3.5% | +12.3% | -11.0% | +4.8% | -0.9% | +13.5% | -10.6% | +6.2% | +0.7% | +11.3% | -14.6% | +8.8% | +0.5% | +36.9% | +12.9% |
| YoY Change | — | — | — | — | -0.1% | +0.2% | +0.3% | +1.0% | +1.2% | +3.9% | +5.0% | +5.4% | +6.8% | +8.5% | +6.4% | +1.6% | +4.2% | +4.0% | +27.9% | +69.2% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Integrated Media | — | — | — | — | — | — | — | $2.98B |
| Advertising | $2.10B | $2.13B | $2.47B | $674.60M | $2.29B | $2.35B | $3.32B | $1.06B |
| Experiential & Other | $182.40M | $174.30M | $207.00M | $552.30M | $196.80M | $152.20M | $359.50M | $922.00M |
| Public Relations | $407.90M | $404.00M | $445.50M | $359.10M | $372.90M | $377.20M | $500.80M | $696.60M |
| Health | $345.10M | $337.10M | $338.00M | $299.00M | $332.60M | $331.20M | $410.40M | $585.70M |
| Branding & Retail Commerce | — | — | $177.10M | $159.50M | $148.60M | $144.80M | $164.70M | — |
| Commerce & Branding | $199.30M | $199.00M | — | — | — | — | — | — |
| Execution & Support | $208.20M | $205.90M | $209.50M | $209.80M | $216.30M | $215.40M | $202.20M | — |
| Precision Marketing | $427.10M | $450.60M | $473.20M | $450.30M | $457.10M | $462.50M | $568.60M | — |
| Total | $3.85B | $3.88B | $4.32B | $3.69B | $4.02B | $4.04B | $5.53B | $6.24B |
Branding & Retail Commerce, Commerce & Brand Consulting, Commerce & Branding, CRM Execution & Support, CRM Precision Marketing, Execution & Support, Experiential, Precision Marketing were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $3.69B | $4.02B | $4.04B | $5.53B | $6.24B |
| Total | $3.69B | $4.02B | $4.04B | $5.53B | $6.24B |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Europe | $1.10B | $1.08B | $1.25B | $995.00M | $1.17B | $1.14B | $1.51B | $1.44B |
| Asia-Pacific | $431.50M | $484.80M | $523.00M | $416.70M | $458.80M | $462.60M | $587.30M | $578.50M |
| Latin America | $106.40M | $99.70M | $131.10M | $96.40M | $114.60M | $126.40M | $202.80M | $196.10M |
| Middle East and Africa | $65.60M | $63.30M | $110.70M | $70.80M | $66.10M | $67.40M | $204.90M | $144.20M |
| Total | $3.85B | $3.88B | $4.32B | $3.69B | $4.02B | $4.04B | $5.53B | $6.24B |